Showing results (351-360 of 464) with videos related to
Sort By:
Pageof 47
Haematologica|August 24, 1999
Outcome of biphenotypic acute leukemiaS Killick, E Matutes, R L Powles, et al.British Journal of Haematology|February 1, 1997
Additional chromosome abnormalities confer worse prognosis in acute promyelocytic leukaemiaL R Hiorns, G J Swansbury, J Mehta, et al.Genes, Chromosomes & Cancer|June 1, 1995
Characterization of a t(10;11)(p13-14;q14-21) in the monoblastic cell line U937J Shipley, S Williams, A O'Byrne, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Evaluation of the efficacy of the VEEP regimen in adult Hodgkin's disease with assessment of gonadal and cardiac toxicityM Hill, S Milan, D Cunningham, et al.Scandinavian Journal of Haematology|July 1, 1986
Coexpression of T- and B-markers in a lymphoproliferative disorderJ F San Miguel, L Foroni, M González, et al.Clinical and Laboratory Haematology|January 1, 1985
Osteolytic lesion as the presenting feature of chronic granulocytic leukaemiaA B Mehta, J Tavares De Castro, J F San Miguel, et al.Blood|October 6, 1997
Rapid molecular cloning of rearrangements of the IGHJ locus using long-distance inverse polymerase chain reactionT G Willis, D M Jadayel, L J Coignet, et al.Leukemia Research|January 1, 1983
1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cellsD M McCarthy, J F San Miguel, H C Freake, et al.British Journal of Cancer|September 1, 1993
EPIC: an effective low toxicity regimen for relapsing lymphomaT Hickish, A Roldan, D Cunningham, et al.British Journal of Haematology|February 15, 2002
An oxaliplatin-based chemotherapy in patients with relapsed or refractory intermediate and high-grade non-Hodgkin's lymphomaI Chau, A Webb, D Cunningham, et al.Pageof 47